BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Target Hit|| Long (1Y)
JP Morgan maintains neutral on Sun Pharma
JP Morgan says it expects Sun Pharma to post strong results in the next few quarters and turnaround in Ranbaxy could also be a strong catalyst.